1-(4-(Morpholinomethyl)phenyl)ethanone, 97%, 250mg

4-(5-Chloro-2-ethoxy-4-fluorobenzamido)-3,3-dimethylbutanoic acid, 97%, 250mg

(2R)-4-(Phenylmethyl)-2-morpholinemethanamine, 95.0%, 5g

(5,6-Diphenyl-furo[2,3-d]pyrimidin-4-ylamino)-acetic acid, 93.0%, 500mg

2,4,6-Tri(4-pyridyl)-1,3,5-triazine, 95.0%, 1g

Methyl 5-Amino-2-chlorobenzoate>98.0%(T)5g

Ethyl 3-bromo-6-cyclopropylpicolinate, 97%, 100mg

1H-Isoindole-1,3(2H)-dione, 5-[5-[[(5Z)-3-(4-bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene]methyl]-2-furanyl]-, 97%, 5mg

Hexyl isobutyrate, 95.0%, 500g

(4S,4'S)-2,2'-(4-Bromopyridine-2,6-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 98%, 1g

(S)-2-tert-Butoxycarbonyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 5g

3,4-Dimethyl-3-hexanol>99.0%(GC)10mL

Microliter syringe MICROLITER® series 7000 Point type 2, 0.5 µl, 7000.5 KH, 1 Piece